Paul G. Mathew, MD, DNBPAS, FAAN, FAHS completed his neurology residency at Temple University Hospital in Philadelphia, PA, and then completed a fellowship in headache medicine at Mayo Clinic in Rochester, MN. He is board certified in neurology and headache medicine. He is currently an Assistant Professor of Neurology at Harvard Medical School (HMS), and an Affiliate Member of the HMS Division of Sleep Medicine. He holds positions at three HMS affiliated institutions. He has clinical appointments at Mass General Brigham Health and Atrius Health, as well as a teaching appointment at the Cambridge Health Alliance. As part of his headache and sports neurology/concussion practice, Dr. Mathew performs Botox injections, nerve blocks, and trigger point injections.
In terms of his academic responsibilities, he has been involved in the education of countless neurology, psychiatry, internal medicine, family medicine, dental medicine, pain medicine, and headache medicine trainees. He has written over 90 publications, and has presented at both national and international conferences. Dr. Mathew has served as a peer reviewer for multiple journals including the American Journal of Managed Care, the British Medical Journal, Cephalalgia, the Cleveland Clinic Journal of Medicine, Expert Opinion on Pharmacotherapy, Headache, Headache Currents, the Journal of Neuroimaging, Mayo Clinic Proceedings, Molecular Genetics & Genomic Medicine, Neurology, the New England Journal of Medicine, Pain Medicine, and Sleep. He is the Co-Chief Medical Editor of the journal Practical Neurology. He is an active member of several medical societies including the American Academy of Neurology, the Massachusetts Neurological Association, the International Headache Society, the American College of Sports Medicine, and the American Association of Physicians of Indian Origin. He is the current Chair of the American Headache Society’s Trigeminal Autonomic Cephalgia Section, a Member of the Board of the Directors of the National Headache Foundation, an Executive Board Member of the Indian Medical Association of New England, and an Executive Board Member of the New England Chapter of the American College of Sports Medicine.
As a graduate of the American Academy of Neurology’s Palatucci Advocacy Leadership Forum, Dr. Mathew applies his passion and expertise to the role of advocate for both patients and fellow physicians. He has participated in multiple successful lobbying efforts in Washington, DC headed by the American Academy of Neurology and the Alliance for Headache Advocacy to improve patient access to healthcare and research funding. In addition, Dr. Mathew applies his passion for patient education/advocacy having served as a contributor on the Harvard Medical School Health Blog (www.health.harvard.edu/blog/author/pgmathew), Migraine Again (www.migraineagain.com), the Migraine World Summit (https://migraineworldsummit.com/), and Miles for Migraine (https://www.milesformigraine.org/).
In March, 2015, Dr. Mathew was appointed as the neurology representative on the advisory board of the National Board of Physicians and Surgeons (www.NBPAS.org). The National Board of Physicians and Surgeons is an organization committed to providing board re-certification that ensures physician compliance with national standards and lifelong learning after completing initial board certification with a member board of the American Board of Medical Specialties (ABMS) or the American Osteopathic Association (AOA).
His advocacy work also includes diversity, equity, and inclusion (DEI) efforts in the domains of race, ethnicity, gender, and age. Since 2020, he has served on the Diversity Committee of the New England Chapter of the American College of Sports Medicine. He has also given a lecture titled “Ten Action Items To Combat Peer to Peer and Institutional Racial Bias In Medicine” to multiple state/regional medical societies, and a manuscript by the same name is currently under peer review. Through his leadership positions within Practical Neurology, AAN, AHS, NHF, and NBPAS, he has lobbied for underrepresented groups in medicine to have greater leadership, speaking, authorship, and editorial opportunities.
